Tumor immunosurveillance by ILCs has been proposed for type-1-like ILC1s which are defined as TCR-NK1.1+CD49ahiT-bet+EOMESloIL7R-NKp46+ (Figure 1 and Table 2). The gene discussed is NCR1; the disease is neoplasm.